• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The need for a quality control of the whole process of immunohistochemistry human epidermal growth factor receptor 2/neu determination: a United Kingdom National External Quality Assessment Service/Italian Network for Quality Assessment of Tumor Biomarkers pilot experience.

作者信息

Paradiso Angelo, Miller Keith, Marubini Ettore, Pizzamiglio Sara, Verderio Paolo

出版信息

J Clin Oncol. 2007 Aug 1;25(22):e27-8. doi: 10.1200/JCO.2006.10.5155.

DOI:10.1200/JCO.2006.10.5155
PMID:17664462
Abstract
摘要

相似文献

1
The need for a quality control of the whole process of immunohistochemistry human epidermal growth factor receptor 2/neu determination: a United Kingdom National External Quality Assessment Service/Italian Network for Quality Assessment of Tumor Biomarkers pilot experience.
J Clin Oncol. 2007 Aug 1;25(22):e27-8. doi: 10.1200/JCO.2006.10.5155.
2
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial.由北中部癌症治疗组N9831组间辅助试验标本的当地、中心和参考实验室进行的HER2检测。
J Clin Oncol. 2006 Jul 1;24(19):3032-8. doi: 10.1200/JCO.2005.03.4744.
3
HER-2 testing in breast cancer using parallel tissue-based methods.使用基于组织的平行方法检测乳腺癌中的HER-2
JAMA. 2004 Apr 28;291(16):1972-7. doi: 10.1001/jama.291.16.1972.
4
HER2 testing in breast carcinoma: very low concordance rate between reference and local laboratories in Brazil.乳腺癌中的HER2检测：巴西参考实验室与当地实验室之间的一致性率极低。
Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):112-8. doi: 10.1097/PAI.0b013e3181f0b044.
5
Updated UK Recommendations for HER2 assessment in breast cancer.英国乳腺癌HER2评估的最新建议。
J Clin Pathol. 2015 Feb;68(2):93-9. doi: 10.1136/jclinpath-2014-202571. Epub 2014 Dec 8.
6
HER2+ breast cancer: review of biologic relevance and optimal use of diagnostic tools.人表皮生长因子受体2阳性乳腺癌：生物学相关性及诊断工具最佳应用的综述
Am J Clin Pathol. 2008 Feb;129(2):263-73. doi: 10.1309/99AE032R9FM8WND1.
7
[Quality assured HER2 analysis in breast cancer. Important therapeutic predictive and prognostic factor].[乳腺癌中质量有保证的HER2分析。重要的治疗预测和预后因素]
Lakartidningen. 2008;105(32-33):2181-4.
8
[HER2 testing in breast cancer].[乳腺癌中的人表皮生长因子受体2检测]
Nihon Rinsho. 2007 Jun 28;65 Suppl 6:275-80.
9
HER-2 and fluorescent in situ hybridization to evaluate breast cancer.
JAMA. 2004 Jul 21;292(3):328; author reply 328-9. doi: 10.1001/jama.292.3.328-a.
10
HER2/neu role in breast cancer: from a prognostic foe to a predictive friend.HER2/neu在乳腺癌中的作用：从预后的“敌人”到预测的“朋友”
Curr Opin Obstet Gynecol. 2007 Feb;19(1):56-62. doi: 10.1097/GCO.0b013e328012980a.

引用本文的文献

1
Biomarker phenotyping drives clinical management in axillary sentinel node: A retrospective study on women with primary breast cancer in 2002.生物标志物表型分析推动腋窝前哨淋巴结的临床管理：一项针对2002年原发性乳腺癌女性患者的回顾性研究。
Oncol Lett. 2020 Sep;20(3):2469-2476. doi: 10.3892/ol.2020.11793. Epub 2020 Jul 1.
2
External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale.乳腺癌中HER2的分析前和分析免疫组织化学测定的外部质量评估（EQA）计划：区域规模的经验
J Exp Clin Cancer Res. 2013 Aug 21;32(1):58. doi: 10.1186/1756-9966-32-58.
3
Tissue microarrays for immunohistochemical determination of oncological biomarkers.
Virchows Arch. 2009 Mar;454(3):353-4. doi: 10.1007/s00428-009-0737-7. Epub 2009 Feb 4.